Adäquate Antiinfektivatherapie: Bedeutung der individuellen Dosierung und Applikation

Standard

Adäquate Antiinfektivatherapie: Bedeutung der individuellen Dosierung und Applikation. / Brinkmann, A; Röhr, A C; Köberer, A; Fuchs, T; Krüger, W A; König, C; Richter, D; Weigand, M A; Frey, O R.

In: ANAESTHESIST, Vol. 67, No. 6, 06.2018, p. 461-476.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

Brinkmann, A, Röhr, AC, Köberer, A, Fuchs, T, Krüger, WA, König, C, Richter, D, Weigand, MA & Frey, OR 2018, 'Adäquate Antiinfektivatherapie: Bedeutung der individuellen Dosierung und Applikation', ANAESTHESIST, vol. 67, no. 6, pp. 461-476. https://doi.org/10.1007/s00101-018-0443-4

APA

Brinkmann, A., Röhr, A. C., Köberer, A., Fuchs, T., Krüger, W. A., König, C., Richter, D., Weigand, M. A., & Frey, O. R. (2018). Adäquate Antiinfektivatherapie: Bedeutung der individuellen Dosierung und Applikation. ANAESTHESIST, 67(6), 461-476. https://doi.org/10.1007/s00101-018-0443-4

Vancouver

Bibtex

@article{6cbb6ddb0cb14736aa650b399ef645f5,
title = "Ad{\"a}quate Antiinfektivatherapie: Bedeutung der individuellen Dosierung und Applikation",
abstract = "Sepsis-induced changes in pharmacokinetic parameters are a well-known problem in intensive care medicine. Dosing of antibiotics in this setting is therefore challenging. Alterations to the substance-specific kinetics of anti-infective substances have an effect on the distribution and excretion processes in the body. Increased clearance and an increased distribution volume (Vd) and particularly compromized organ function with reduced antibiotic elimination are often encountered in patients with sepsis. Renal replacement treatment, which is frequently used in intensive care medicine, represents a substantial intervention in this system. Current international guidelines recommend individualized dosing strategies and adaptation of doses according to measured serum levels and pharmacokinetic/pharmacodynamic (PK/PD) parameters as concepts to optimize anti-infective therapy in the critically ill. Likewise, the recommendation to adjust the administration form of beta-lactam antibiotics to prolonged or continuous infusion can be found increasingly more often in the literature. This article reviews the background of the individual dosing in intensive care patients and their applicability to the clinical routine.",
keywords = "English Abstract, Journal Article, Anti-Bacterial Agents/administration & dosage, Critical Care, Drug Monitoring, Humans, Precision Medicine, Sepsis/drug therapy, Shock, Septic/drug therapy",
author = "A Brinkmann and R{\"o}hr, {A C} and A K{\"o}berer and T Fuchs and Kr{\"u}ger, {W A} and C K{\"o}nig and D Richter and Weigand, {M A} and Frey, {O R}",
note = "CME Fortbildungsbeitrag",
year = "2018",
month = jun,
doi = "10.1007/s00101-018-0443-4",
language = "Deutsch",
volume = "67",
pages = "461--476",
journal = "ANAESTHESIST",
issn = "0003-2417",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - Adäquate Antiinfektivatherapie: Bedeutung der individuellen Dosierung und Applikation

AU - Brinkmann, A

AU - Röhr, A C

AU - Köberer, A

AU - Fuchs, T

AU - Krüger, W A

AU - König, C

AU - Richter, D

AU - Weigand, M A

AU - Frey, O R

N1 - CME Fortbildungsbeitrag

PY - 2018/6

Y1 - 2018/6

N2 - Sepsis-induced changes in pharmacokinetic parameters are a well-known problem in intensive care medicine. Dosing of antibiotics in this setting is therefore challenging. Alterations to the substance-specific kinetics of anti-infective substances have an effect on the distribution and excretion processes in the body. Increased clearance and an increased distribution volume (Vd) and particularly compromized organ function with reduced antibiotic elimination are often encountered in patients with sepsis. Renal replacement treatment, which is frequently used in intensive care medicine, represents a substantial intervention in this system. Current international guidelines recommend individualized dosing strategies and adaptation of doses according to measured serum levels and pharmacokinetic/pharmacodynamic (PK/PD) parameters as concepts to optimize anti-infective therapy in the critically ill. Likewise, the recommendation to adjust the administration form of beta-lactam antibiotics to prolonged or continuous infusion can be found increasingly more often in the literature. This article reviews the background of the individual dosing in intensive care patients and their applicability to the clinical routine.

AB - Sepsis-induced changes in pharmacokinetic parameters are a well-known problem in intensive care medicine. Dosing of antibiotics in this setting is therefore challenging. Alterations to the substance-specific kinetics of anti-infective substances have an effect on the distribution and excretion processes in the body. Increased clearance and an increased distribution volume (Vd) and particularly compromized organ function with reduced antibiotic elimination are often encountered in patients with sepsis. Renal replacement treatment, which is frequently used in intensive care medicine, represents a substantial intervention in this system. Current international guidelines recommend individualized dosing strategies and adaptation of doses according to measured serum levels and pharmacokinetic/pharmacodynamic (PK/PD) parameters as concepts to optimize anti-infective therapy in the critically ill. Likewise, the recommendation to adjust the administration form of beta-lactam antibiotics to prolonged or continuous infusion can be found increasingly more often in the literature. This article reviews the background of the individual dosing in intensive care patients and their applicability to the clinical routine.

KW - English Abstract

KW - Journal Article

KW - Anti-Bacterial Agents/administration & dosage

KW - Critical Care

KW - Drug Monitoring

KW - Humans

KW - Precision Medicine

KW - Sepsis/drug therapy

KW - Shock, Septic/drug therapy

U2 - 10.1007/s00101-018-0443-4

DO - 10.1007/s00101-018-0443-4

M3 - Andere (Vorworte u.ä.)

C2 - 29766208

VL - 67

SP - 461

EP - 476

JO - ANAESTHESIST

JF - ANAESTHESIST

SN - 0003-2417

IS - 6

ER -